ATE225647T1 - Dosierungsform zur verabreichung von flüssige arzneimittel formulierung - Google Patents

Dosierungsform zur verabreichung von flüssige arzneimittel formulierung

Info

Publication number
ATE225647T1
ATE225647T1 AT94920203T AT94920203T ATE225647T1 AT E225647 T1 ATE225647 T1 AT E225647T1 AT 94920203 T AT94920203 T AT 94920203T AT 94920203 T AT94920203 T AT 94920203T AT E225647 T1 ATE225647 T1 AT E225647T1
Authority
AT
Austria
Prior art keywords
dosage form
administration
medicinal formulation
liquid medicinal
liquid
Prior art date
Application number
AT94920203T
Other languages
English (en)
Inventor
Steven D Larsen
George V Guittard
Patrick S-L Wong
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE225647T1 publication Critical patent/ATE225647T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94920203T 1994-06-13 1994-06-13 Dosierungsform zur verabreichung von flüssige arzneimittel formulierung ATE225647T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/006723 WO1995034285A1 (en) 1994-06-13 1994-06-13 Dosage form for administering drug in liquid formulation

Publications (1)

Publication Number Publication Date
ATE225647T1 true ATE225647T1 (de) 2002-10-15

Family

ID=22242671

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920203T ATE225647T1 (de) 1994-06-13 1994-06-13 Dosierungsform zur verabreichung von flüssige arzneimittel formulierung

Country Status (11)

Country Link
EP (1) EP0768867B1 (de)
JP (1) JP3901727B2 (de)
KR (1) KR100360636B1 (de)
AT (1) ATE225647T1 (de)
AU (1) AU682703B2 (de)
CA (1) CA2185119C (de)
DE (1) DE69431533T2 (de)
DK (1) DK0768867T3 (de)
ES (1) ES2183841T3 (de)
PT (1) PT768867E (de)
WO (1) WO1995034285A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
AU748334B2 (en) 1997-10-16 2002-05-30 Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with NF-AT3 function
CN1227003C (zh) * 1998-09-09 2005-11-16 阿尔萨公司 包括液体制剂的剂型
AU765909C (en) * 1998-12-17 2004-09-23 Alza Corporation Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
AU2003287301A1 (en) * 2002-10-31 2004-06-07 Alza Corporation Dosage form providing ascending release of liquid formulation
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US8246986B2 (en) 2003-09-26 2012-08-21 Alza Corporation Drug coating providing high drug loading
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
CA2670821C (en) 2006-08-09 2012-05-15 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
CA2683610C (en) 2007-04-23 2013-01-08 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
CA2691531C (en) 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
WO2010056657A2 (en) 2008-11-16 2010-05-20 Board Of Regents, The Univesity Of Texas System Low viscosity highly concentrated suspensions
MX378797B (es) 2009-09-28 2025-03-10 Intarcia Therapeutics Inc Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CN113598842A (zh) 2015-06-03 2021-11-05 因塔西亚制药公司 植入物放置和移除系统
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
WO2018129058A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
ES2909803T3 (es) 2018-03-05 2022-05-10 Amneal Complex Products Res Llc Composiciones farmacéuticas programables para la cronoliberación de fármacos
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
US11547670B2 (en) 2019-03-05 2023-01-10 Amneal Complex Products Research Llc Delayed release methylphenidate compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4814180A (en) * 1984-03-21 1989-03-21 Alza Corporation Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug

Also Published As

Publication number Publication date
EP0768867B1 (de) 2002-10-09
DE69431533T2 (de) 2003-10-02
AU7108094A (en) 1996-01-05
JPH10501261A (ja) 1998-02-03
KR100360636B1 (ko) 2002-12-18
EP0768867A1 (de) 1997-04-23
PT768867E (pt) 2003-01-31
CA2185119C (en) 2005-07-26
CA2185119A1 (en) 1995-12-21
DE69431533D1 (de) 2002-11-14
JP3901727B2 (ja) 2007-04-04
AU682703B2 (en) 1997-10-16
DK0768867T3 (da) 2002-10-28
KR970703752A (ko) 1997-08-09
ES2183841T3 (es) 2003-04-01
WO1995034285A1 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
DE69431533D1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
DE69106501D1 (de) Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
MX171191B (es) Composiciones farmaceuticas de glipizida
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
EP0693924A4 (de) Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
ATE298561T1 (de) Orale dareichungsform
EP0458894A4 (de) Lipidhilfstoffe für verabreichung durch die nase und örtliche anwendung.
ES2060593T3 (es) Sistema de aporte de farmacos.
IT1261849B (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
NO874960D0 (no) Flytende doseringsform for oral administrasjon av et farmasoeytisk aktivt stoff.
ATE427103T1 (de) Orale verabreichung von adenosin analogen
UA41502C2 (uk) Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
ES2165997T3 (es) Uso de una formulacion farmaceutica pediatrica que comprende amoxicilina y clavulanato.
MY101784A (en) Novel pharmacological compounds
ATE292453T1 (de) Antivirale arznei
ES2160821T3 (es) Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
HUP9900751A2 (hu) Parathormontartalmú stabil gyógyászati készítmény
PT705204E (pt) Saquetas para medicamentos liquidos
GR3022742T3 (en) New derivatives of non-steroidal anti-inflammatory, analgesic and/or antipyretic substances, their use and pharmaceutical formulations containing them
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee